Sumita Behera

Title: Sumita Behera: Innovator in Transdermal Drug Delivery

Introduction

Sumita Behera is a prominent inventor based in Irving, TX (US). She has made significant contributions to the field of drug delivery systems, particularly through her innovative work with hyaluronic acid nanoparticles. Her research focuses on developing methods that enhance the efficacy of transdermal drug delivery.

Latest Patents

Sumita Behera holds a patent for a "Method of transdermal drug delivery using hyaluronic acid nanoparticles." This invention relates to the development of hyaluronic acid and hybrid nanoparticle systems for administering active molecules, peptides, DNA, and other hydrophilic or hydrophobic substances. The nanoparticles are composed of hyaluronic acid in salt form, preferably the sodium salt, and can be hybridized with magnetic Fe particles. These biocompatible and biodegradable nanoparticles facilitate the controlled release of active molecules and target specific tissues. The invention outlines a procedure for creating hyaluronic acid particles with a diameter of less than 180 nm, which can incorporate active ingredients regardless of their nature.

Career Highlights

Sumita Behera is affiliated with the University of South Florida, where she continues her research and development in the field of drug delivery systems. Her work has garnered attention for its potential applications in medicine and pharmaceuticals.

Collaborations

Sumita has collaborated with notable colleagues, including Bishwabhusan Sahoo and Arun Babu Kumar, to advance her research initiatives and explore new avenues in drug delivery technology.

Conclusion

Sumita Behera's innovative work in transdermal drug delivery using hyaluronic acid nanoparticles represents a significant advancement in the field. Her contributions are poised to impact the future of medical treatments and drug administration methods.